We all have tens of thousands of biomarkers contained within our blood. Some may sound familiar already. Cholesterol. Hemoglobin A1C. Thyroid-stimulating hormone. The blood moves these important proteins throughout the body — and by measuring their levels to see if they're comparatively high or low in your body, we can uncover vital information about you, your health, and life-threatening conditions that are silently developing.
With serious conditions like heart disease and diabetes, biomarkers in your blood start to change years before you notice symptoms. imaware helps you decode this information so you can work with your doctor to improve your health and prevent serious illnesses from taking hold.
Normally, when you need a blood test, you go to a testing center. A technician draws your blood and sends it to a lab for analysis — but delays are frequent. The sample may be sent late or processed slowly, and it can take even more time for your doctor to pass on your results. It isn’t cheap, either. Lab companies charge high prices, due to the costs of staffing testing centers and the challenges of reimbursement.
imaware puts control directly into the patient’s hands, removing the need for a lab visit, and lets you test yourself from the comfort of home. When you order a test, we immediately ship you the appropriate kit. You pay upfront, and because we negotiate bulk prices for our tests, it’ll cost you a fraction of the price you’d pay at a regular testing center and still involves physician analysis every step of the way. It also means you can test yourself as often as needed to make sure you’re on the right track to optimal health.
We don’t simply work with doctors. We also work with chairs of departments and research scientists who have been studying disease prevention for their entire careers. They drive our decisions at every stage, including which biomarkers we choose to test and the best scientific methods for each.
During the development stage of new tests, we’re always asking the same key questions:
Not all tests out there provide information that is clear and actionable. For example, some tests might reveal that a patient has a slightly increased risk for a disease, but then what? At imaware, we’re determined to help patients sort out the signal from the noise. We only pursue the tests that our experts agree will empower our patients to take control of their health.
Our lab partners don’t just have high standards, they have the highest standards. All of our labs are certified by Clinical Laboratory Improvement Amendments (CLIA) and accredited by the College of American Pathologists (CAP).
CLIA certification is required for all labs licensed by the Centers for Medicare and Medicaid Services. CLIA-certified labs must continually meet a wide range of quality standards on equipment, technical protocols, and testing sensitivity.
As soon as your digital results are available, you’ll be able to view them on our secure platform. We follow all HIPAA standards to keep your data safe, implementing two-factor authentication as well as HL7 and API encryption technologies.
You won’t simply see that your result is ‘positive or negative’. When you get your results, you can view your exact biomarker readings. You’ll also receive a detailed and easy-to-understand explainer that breaks down what the numbers mean. With our portal, you can track these numbers over time, allowing you to understand what’s normal for you, and pick up early warning signs of poor health.
Your health data is yours, which is why our system lets you print or share your results with your doctor, pharmacist or other health professional, as you wish.
Iyer, A.S. et al. (2018). Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses. PLoS Neglected Tropical Diseases, 12(1): e0006196.
Mathieu, R., et al. (2015). Hemoglobin A1c Screening using ADx100 Dried Blood Spot Collection Cards on the Trinity Primus Affinity Ultra2 Analyzer. Clinical Chemistry, 61(10): S192.
Mathieu, R., et al. (2013). Lipid Screening from Dried Blood Spots using a Modified Curve on the Siemens ADVIA 2400 Instrument Platform. Clinical Chemistry, 59(10): A269.
Mathieu, R., et al. (2013). Quantification of Testosterone from Dried Blood Spots using Liquid Chromatography Tandem Mass Spectrometry. Clinical Chemistry, 59(10): A63.
Terryberry, J., et al. (2019). Diagnostic accuracy of a fully automated multiplex celiac disease antibody panel for serum and plasma. Clinical Chemistry and Laboratory Medicine, 57(8): 1207-1217.
